UNSPSC 51434108: Pentamethonium bromide

This classification denotes a nicotinic antagonist with the molecular formula C11H28N2.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UX03A6JJC, chemically known as 1,5-pentanediaminium, n,n,n,n,n,n-hexamethyl-, dibromide (9ci) but more generally known as pentamethonium bromide, which bears US NIH Compound Identifier 10919. European Medicines Agency schedules Pentamethonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09681MIG.

UNSPSC 51434108 Pentamethonium bromide is a Commodity code that nominally identifies a specific pharmaceutical agent, but recent state and local solicitations show little activity directly aligned with this compound. The three most recent opportunities posted under or near this code actually address broader pharmaceutical procurement — emergency medical supplies, direct-to-manufacturer prescription programs, and generic multi-source drug distribution — rather than pentamethonium bromide specifically. State and local issuing bodies using pharmaceutical codes in this family include municipal fire and rescue departments (city purchasing offices), state health agencies, and cooperative purchasing consortia. The scope of work under this code family spans emergency life support medications, generic pharmaceutical distribution through authorized wholesalers, and pharmacy benefit program innovation, with vendors typically required to maintain FDA compliance, cGMP certification, Drug Supply Chain Security Act compliance, and expiration-dating standards of six months to one year minimum shelf life.

Geographically, recent opportunities appear in Florida (Tampa), Texas (state-level HHS), and Minnesota (multistate cooperative), reflecting activity across municipal, state, and regional cooperative purchasing vehicles. The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) in April 2026 for Advanced Life Support Medications—Labetalol HCI, Epinephrine, Adenosine, and Diltiazem vials for Tampa Fire Rescue—with a firm-price requirement, ten-day delivery, and a 5 percent SLBE bid discount; the contract term runs one year with two optional one-year renewals and estimated value of $40,000. The Texas Health and Human Services Commission issued an RFI in April 2026 to explore vendor capabilities for direct-to-manufacturer prescription contracting outside traditional PBM and GPO channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP due March 26, 2026, seeking generic pharmaceuticals and OTC products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), with contract effectiveness July 1, 2026, and evaluation weighted 75 percent on price competitiveness. This code shows limited recent pentamethonium bromide–specific procurement; vendors should verify actual commodity demand before pursuing opportunities posted under this classification.